MedTrace Logo

Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention

NCT00689377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9000

Last updated 2012-03-20

No results posted yet for this study

Summary

Non interventional study aimed to establish the prevalence of lower extremity peripheral arterial disease (PAD), defined as an ankle-brachial index (ABI) not above 0.90 in subjects with a moderate risk of cardiovascular disease, with no overt cardiovascular diseases nor diabetes mellitus.

Conditions

  • Peripheral Arterial Disease (PAD)
  • Moderate Risk for Cardiovascular Disease (CVD)

Sponsors & Collaborators

Principal Investigators

  • Raffaele Sabia · AstraZeneca S.p.A.

  • Mario Mangrella · AstraZeneca S.p.A

  • Claudio Cimminiello · Unit of Medicine, Vimercate Hospital - Vimercate (MI) - Italy

  • Claudio Borghi · Internal Medicine Dept., di Medicina Interna, Policlinico Universitario Sant'Orsola-Malpighi, Bologna, Italy

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • Belgium
  • France
  • Greece
  • Italy
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00689377 on ClinicalTrials.gov